Deirdre Murphy

Prof. Deirdre Murphy


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2001 in BMJ
Verified
Journal Article
Closed access
PDF file
MWMark Waterstone
Mark Waterstone
DMDeirdre Murphy
Deirdre Murphy
SBSusan Bewley
Susan Bewley
CWCharles Wolfe
Charles Wolfe
Objective: To estimate the incidence and predictors of severe obstetric morbidity. Design: Development of definitions of severe obstetric morbidity by literature review. Case-control study from a defined delivery population with four randomly selected pregnant women as controls for every case. Setting: All 19 maternity units within the South East Thames region and six neighbouring hospitals caring for pregnant women from the region between 1 March 1997 and 28 February 1998. Participants: 48 865 women who delivered during the time frame. Results: There were 588 cases of severe obstetric morbidity giving an incidence of 12.0/1000 deliveries (95% confidence interval 11.2 to 13.2). During the study there were five maternal deaths attributed to conditions studied. Disease specific morbidities per 1000 deliveries were 6.7 (6.0 to 7.5) for severe haemorrhage, 3.9 (3.3 to 4.5) for severe pre-eclampsia, 0.2 (0.1 to 0.4) for eclampsia, 0.5 (0.3 to 0.8) for HELLP (Haemolysis, Elevated Liver enzymes, and Low Platelets) syndrome, 0.4 (0.2 to 0.6) for severe sepsis, and 0.2 (0.1 to 0.4) for uterine rupture. Age over 34 years, non-white ethnic group, past or current hypertension, previous postpartum haemorrhage, delivery by emergency caesarean section, antenatal admission to hospital, multiple pregnancy, social exclusion, and taking iron or anti-depressants at antenatal booking were all independently associated with morbidity after adjustment. Conclusion: Severe obstetric morbidity and its relation to mortality may be more sensitive measures of pregnancy outcome than mortality alone. Most events are related to obstetric haemorrhage and severe pre-eclampsia. Caesarean section quadruples the risk of morbidity. Development and evaluation of ways of predicting and reducing risk are required with particular emphasis paid on the management of haemorrhage and pre-eclampsia. What is already known on this topic: Maternal mortality is used internationally as a measure of the quality of obstetric intervention, although it is now rare in the developed world Hospital based series estimating the incidence of severe obstetric morbidity have used different definitions Estimated incidence of severe obstetric morbidity ranges from 0.05 to 1.09 What this study adds: With clear definitions and population based estimates of some severe obstetric morbidities this study estimated the overall incidence of severe obstetric morbidity as 1.2 % of deliveries Two thirds of the cases are related to severe haemorrhage, one third to hypertensive disorders Risk factors for severe maternal morbidity include maternal age >34, social exclusion, non-white, hypertension, previous postpartum haemorrhage, induction of labour, and caesarean section

1 December 1995 in The Lancet
Verified
Journal Article
Closed access
DMDeirdre Murphy
Deirdre Murphy
AJA.M Johnson
A.M Johnson
SSS Sellers
S Sellers
IMI.Z MacKenzie
I.Z MacKenzie

1 October 2001 in The Lancet
Verified
Journal Article
Closed access
DMDeirdre Murphy
Deirdre Murphy
RLRachel E Liebling
Rachel E Liebling
LVLisa Verity
Lisa Verity
RSRebecca Swingler
Rebecca Swingler
RPRoshni Patel
Roshni Patel

10 March 2005 in BMJ
Verified
Journal Article
Open access
PDF file
FMFiona Milne
Fiona Milne
CRChris Redman
Chris Redman
JWJames Johnston Walker
James Johnston Walker
PBPhilip Baker
Philip Baker
JBJulian Bradley
Julian Bradley
JWJason Waugh
Jason Waugh
In 46% of maternal deaths1 and 65% of fetal deaths5 due to pre-eclampsia reported through the Confidential Enquiries into Maternal Deaths and the Confidential Enquiry into Stillbirths and Deaths in Infancy, different management would reasonably have expected to alter the outcome. There was a failure to identify and act on known risk factors at booking and to recognise and respond to signs and symptoms from 20 weeks' gestation.6

30 October 2006 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
MIMelanie E Inkster
Melanie E Inkster
TFTom P Fahey
Tom P Fahey
PDPeter T Donnan
Peter T Donnan
GLGraham P Leese
Graham P Leese
GMGary J Mires
Gary J Mires
DMDeirdre Murphy
Deirdre Murphy
Glycaemic control in women with diabetes is critical to satisfactory pregnancy outcome. A systematic review of two randomised trials concluded that there was no clear evidence of benefit from very tight versus tight glycaemic control for pregnant women with diabetes. A systematic review of observational studies addressing miscarriage, congenital malformations and perinatal mortality among pregnant women with type 1 and type 2 diabetes was carried out. Literature searches were performed in MEDLINE, EMBASE, CINAHL and Cochrane Library. Observational studies with data on glycated haemoglobin (HbA1c) levels categorised into poor and optimal control (as defined by the study investigators) were selected. Relative risks and odds ratios were calculated for HbA1c and pregnancy outcomes. Adjusted relative risk estimates per 1-percent decrease in HbA1c were calculated for studies which contained information on mean and standard deviations of HbA1c. The review identified thirteen studies which compared poor versus optimal glycaemic control in relation to maternal, fetal and neonatal outcomes. Twelve of these studies reported the outcome of congenital malformations and showed an increased risk with poor glycaemic control, pooled odds ratio 3.44 (95%CI, 2.30 to 5.15). For four of the twelve studies, it was also possible to calculate a relative risk reduction of congenital malformation for each 1-percent decrease in HbA1c, these varied from 0.39 to 0.59. The risk of miscarriage was reported in four studies and was associated with poor glycaemic control, pooled odds ratio 3.23 (95%CI, 1.64 to 6.36). Increased perinatal mortality was also associated with poor glycaemic control, pooled odds ratio 3.03 (95%CI, 1.87 to 4.92) from four studies. This analysis quantifies the increase in adverse pregnancy outcomes in women with diabetes who have poor glycaemic control. Relating percentage risk reduction in HbA1c to relative risk of adverse pregnancy events may be useful in motivating women to achieve optimal control prior to conception.

15 September 2010 in Addiction
Verified
Journal Article
Closed access
PDF file
BCBrian J. Cleary
Brian J. Cleary
JDJean Donnelly
Jean Donnelly
JSJudith Strawbridge
Judith Strawbridge
PGPaul J. Gallagher
Paul J. Gallagher
TFTom Fahey
Tom Fahey
DMDeirdre Murphy
Deirdre Murphy